PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25033069-5	2014	RESULTS: We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine.	Lysophosphatidylcholines	245-268	patatin like phospholipase domain containing 6	Homo sapiens	101-107	
31835418-1	2019	: Neuropathy target esterase (NTE) is an endoplasmic reticulum (ER)-localized phospholipase that deacylates phosphatidylcholine (PC) and lysophosphatidylcholine (LPC).	Lysophosphatidylcholines	137-160	patatin like phospholipase domain containing 6	Homo sapiens	2-28	
31835418-1	2019	: Neuropathy target esterase (NTE) is an endoplasmic reticulum (ER)-localized phospholipase that deacylates phosphatidylcholine (PC) and lysophosphatidylcholine (LPC).	Lysophosphatidylcholines	137-160	patatin like phospholipase domain containing 6	Homo sapiens	30-33	
31835418-1	2019	: Neuropathy target esterase (NTE) is an endoplasmic reticulum (ER)-localized phospholipase that deacylates phosphatidylcholine (PC) and lysophosphatidylcholine (LPC).	Lysophosphatidylcholines	162-165	patatin like phospholipase domain containing 6	Homo sapiens	2-28	
31835418-1	2019	: Neuropathy target esterase (NTE) is an endoplasmic reticulum (ER)-localized phospholipase that deacylates phosphatidylcholine (PC) and lysophosphatidylcholine (LPC).	Lysophosphatidylcholines	162-165	patatin like phospholipase domain containing 6	Homo sapiens	30-33	
25033069-5	2014	RESULTS: We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine.	Lysophosphatidylcholines	245-268	patatin like phospholipase domain containing 6	Homo sapiens	123-149	
25033069-5	2014	RESULTS: We identified 6 patients from 3 independent families carrying loss-of-function mutations in PNPLA6, which encodes neuropathy target esterase (NTE), a lysophospholipase that maintains intracellular phospholipid homeostasis by converting lysophosphatidylcholine to glycerophosphocholine.	Lysophosphatidylcholines	245-268	patatin like phospholipase domain containing 6	Homo sapiens	151-154	
17663017-1	2007	Brain neuropathy target esterase (NTE), associated with organophosphorus (OP)-induced delayed neuropathy, has the same OP inhibitor sensitivity and specificity profiles assayed in the classical way (paraoxon-resistant, mipafox-sensitive hydrolysis of phenyl valerate) or with lysophosphatidylcholine (LysoPC) as the substrate.	Lysophosphatidylcholines	276-299	patatin like phospholipase domain containing 6	Homo sapiens	6-32	
18706436-5	2008	We find the same inhibitor sensitivity and specificity profiles for rNTE assayed with LPC or phenyl valerate (a standard NTE substrate) and that this correlation extends to the LPC hydrolases of human brain, lymphocytes and erythrocytes.	Lysophosphatidylcholines	86-89	patatin like phospholipase domain containing 6	Homo sapiens	69-72	
17663017-1	2007	Brain neuropathy target esterase (NTE), associated with organophosphorus (OP)-induced delayed neuropathy, has the same OP inhibitor sensitivity and specificity profiles assayed in the classical way (paraoxon-resistant, mipafox-sensitive hydrolysis of phenyl valerate) or with lysophosphatidylcholine (LysoPC) as the substrate.	Lysophosphatidylcholines	276-299	patatin like phospholipase domain containing 6	Homo sapiens	34-37	
17663017-1	2007	Brain neuropathy target esterase (NTE), associated with organophosphorus (OP)-induced delayed neuropathy, has the same OP inhibitor sensitivity and specificity profiles assayed in the classical way (paraoxon-resistant, mipafox-sensitive hydrolysis of phenyl valerate) or with lysophosphatidylcholine (LysoPC) as the substrate.	Lysophosphatidylcholines	301-307	patatin like phospholipase domain containing 6	Homo sapiens	6-32	
17663017-1	2007	Brain neuropathy target esterase (NTE), associated with organophosphorus (OP)-induced delayed neuropathy, has the same OP inhibitor sensitivity and specificity profiles assayed in the classical way (paraoxon-resistant, mipafox-sensitive hydrolysis of phenyl valerate) or with lysophosphatidylcholine (LysoPC) as the substrate.	Lysophosphatidylcholines	301-307	patatin like phospholipase domain containing 6	Homo sapiens	34-37